Adherence to Medication Regimen in Patients with Severe and Chronic Psychiatric Disorders: A Qualitative Study

Issues in Mental Health Nursing

Volumn 37, Issue 11, 2016, Pages 868-874

  Zarea, Kourosh ^a   Fereidooni Moghadam, Malek ^a   Hakim, Ashrafalsadat ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

CHRONIC DISEASE; HUMAN; IRAN; MEDICATION COMPLIANCE; MENTAL DISORDERS; PSYCHOLOGY;

ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; HUMANS; IRAN; MEDICATION ADHERENCE; MENTAL DISORDERS;

EID: 85002301202     PISSN: 01612840     EISSN: 10964673     Source Type: Journal    
DOI: 10.1080/01612840.2016.1239147     Document Type: Article

References (29)

1. Barkhof, E., Meijer, C. J., de Sonneville, L. M. J., Linszen, D. H, & de Haan, L., (2012). Interventions to improve adherence to antipsychotic medication in patients with schizophrenia–A review of the past decade. European Psychiatry, 27, 9–18.
2. Bowersox, N. W., (December, 2010). Treatment attrition and relapse readmission in psychiatric inpatients:Predictors of treatment engagement and psychiatric relapse. Milwaukee, WI:Marquette University.
3. Byerly, M., Fisher, R., Whatley, K., Holland, R., Varghese, F., Carmody, T, … Rush, A. J., (2005). A comparison of electronic monitoring vs clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Research, 133(2–3), 129–133.
4. Chen, E. Y. H., Hui, C. L. M., Dunn, E. L. W., Miao, M. Y. K., Yeung, W. S., Wong, C. K., … Tang, W. N., (2005). A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients. Schizophrenia Research, 77(1), 99–104.
5. Elo, S., & Kyngas, H., (2008). The qualitative content analysis process. Journal of Advanced Nursing, 62(1), 107–115.
6. Fialko, L., Garety, P. A., Kuipers, E., Dunn, G., Bebbington, P. E., Fowler, D., & Freeman, D., (2008). A large-scale validation study of the Medication Adherence Rating Scale (MARS). Schizophrenia Research, 100(1–3), 53–59.
7. Gaebel, W., Schreiner, A., Bergmans, P., de Arce, R., Rouillon, F., Cordes, J., … Smeraldi, E., (2010). Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine:Results of a long-term, open-label, randomized clinical trial. Neuropsychopharmacology, 35(12), 2367–2377. doi:10.1038/npp.2010.111
8. Graneheim, U. H., & Lundman, B., (2004). Qualitative content analysis in nursing research:Concepts, procedures and measures to achieve trustworthiness. Nurse Education Today, 24, 105–112.
9. Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X., (2008). Interventions for enhancing medication adherence (Review):The Cochrane Collaboration. Cochrane Database of Systematic Reviews, 2008 April 16(2), CD000011. doi:10.1002/14651858.CD000011.pub3.
10. Hudson, T. J., Owen, R R., Thrush, C. R., Armitage, T. L., & Thapa, P., (2008). Guideline implementation and patient tailoring strategies to improve medication adherence for schizophrenia. Journal of Clinical Psychiatry, 69(1), 74–80.
11. Hudson, T. J., Owen, R. R., Thrush, C. R., Han, X., Pyne, J. M., Thapa, P., & Sullivan, G., (2004). A pilot study of barriers to medication adherence in schizophrenia. Journal of Clinical Psychiatry, 65(2), 211–216.
12. Kampman, O., Laippala, P., Vaananen, J., Koivisto, E., Kiviniemi, P., Kilkku, N., & Lehtinen, K., (2002). Indicators of medication compliance in first-episode psychosis. Psychiatry Research, 110(1), 39–48.
13. Kane, J. M., Kishimoto, T., & Correll, C. U., (2013). Non-adherence to medication in patients with psychotic disorders:epidemiology, contributing factors and management strategies. World Psychiatry, 12(3), 216–226.
14. Keck, P., McElroy, B., & Strakowski, S., (1998). Factors associated with pharmacologic non-compliance in patients with mania. Journal of Clinical Psychology, 57, 292–297.
15. Kikkert, M. J., Schene, A. H., Koeter, M. W., Robson, D., Born, A., Helm, H., … Gray, R. J., (2006). Medication adherence in schizophrenia:exploring patients', carers' and professionals' views. Schizophrenia Bulletin, 32(4), 786–794. doi:10.1093/schbul/sbl011
16. Klingberg, S., Schneider, S., Wittorf, A., Buchkremer, G., & Wiedemann, G., (2008). Collaboration in outpatient antipsychotic drug treatment:analysis of potentially influencing factors. Psychiatry Research, 8161(2), 225–234.
17. Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G., & Jeste, D. V., (2002). Prevalence of and risk factors for medication non-adherence in patients with schizophrenia:a comprehensive review of recent literature. Journal of Clinical Psychology, 63(10), 892–909.
18. Lang, K., Meyers, J. L., Korn, J. R., Pharm, S. L., Pharm, M. S., Crivera, C., … Menzin, J., (2010). Medication adherence and hospitalization among patients with schizophrenia treated with antipsychotics. Psychiatric Services, 61(12), 1239–1247.
19. Lehman, A. F., & Steinwachs, D. M., (2003). Evidence-based psychosocial treatment practices in schizophrenia:Lessons from the Patient Outcomes Research Team (PORT) project. Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry, 31, 141–154.
20. Leucht, S., & Heres, S., (2006). Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. Journal of Clinical Psychiatry, 67(5), 3–8.
21. Marder, S. L., & Kane, J. M., (2005). Optimizing pharmacotherapy to maximize outcome in schizophrenia:Optimizing the long-term effectiveness of antipsychotic therapy. Journal of Clinical Psychiatry, 66, 123–125.
22. Okuno, J., Yanagi, H., & Tomura, S., (2001). Is cognitive impairment a risk factor for poor compliance among Japanese elderly in the community? European Journal of Clinical Pharmacology, 57(8), 589–594.
23. Osterberg, L., & Blaschke, T., (2005). Adherence to medication. New England Journal of Medicine, 353(5), 487–497.
24. Perkins, D. O., Gu, H., Weiden, P. J., McEvoy, J. P., Hamer, R. M., & Lieberman, J. A., (2008). Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder:a randomized, double-blind, flexible-dose, multicenter study. Journal of Clinical Psychiatry, 69(1), 106–113.
25. Perlick, D. A., Rosenheck, R. A., Kacynski, R., & Kozma, L., (2004). Medication nonadherence in bipolar disorder:A patient-centered review of research findings. Clinical Approaches in Bipolar Disorders, 3(2), 54–56.
26. Rettenbacher, M., Hofer, A., Eder, U., Hummer, M., Kemmler, G., Weiss, E. M., & Fleischhacker, W. W., (2004). Compliance in schizophrenia:Psychopathology, side effects, and patient's attitudes toward the illness and medication. Journal of Clinical Psychiatry, 65(9), 1211–1218.
27. Sajatovic, M., Velligan, D. I., Weiden, P. J., Valenstein, M. A., & Ogedegbe, G., (2010). Measurement of psychiatric treatment adherence. Journal of Psychosomatic Research, 69(6), 591–599.
28. Velligan, D. I., Lam, F. L., Ereshefsky, L., & Miller, A. L., (2003). Perspectives on medication adherence and atypical antipsychotic medications. Psychiatric Services, 54, 665–667.
29. Weiden, P. J., & Olfson, M., (1995). Cost of relapse in schizophrenia. Schizophrenia Bulletin, 21, 419–429.